Metrion Biosciences Appoints Mark Keogh as Non-Executive Director
Metrion Biosciences Appoints Mark Keogh as Non-Executive Director Appointment strengthens the financial and corporate experience of Metrion's Board in support of the Company's planned international growth Metrion Biosciences Limited ("Metrion"), the specialist ion channel contract research and drug discovery company, today announced the appointment of Mark Keogh as a Non-Executive Director. The appointment follows the Company's recently announced £2.7m new equity investment led by Gresham House Ventures and is intended to strengthen the Board's financial and corporate experience, in support ...
Source: finanznachrichten.de